The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Jay M. Sosenko

Division of Endocrinology

University of Miami

Miami

USA

[email]@med.miami.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Endocrinology, University of Miami, Miami, USA. 2002 - 2012
  • University of Miami, Miami, USA. 2011
  • Corresponding author: Jay M. Sosenko. 2011
  • Diabetes Research Institute, Miami, FL 33136, USA. 2009

References

  1. The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes. Sosenko, J.M., Skyler, J.S., Mahon, J., Krischer, J.P., Beam, C.A., Boulware, D.C., Greenbaum, C.J., Rafkin, L.E., Cowie, C., Cuthbertson, D., Palmer, J.P. Diabetes. Care (2012) [Pubmed]
  2. The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1. Sosenko, J.M., Skyler, J.S., Herold, K.C., Palmer, J.P. Diabetes (2012) [Pubmed]
  3. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Sosenko, J.M., Skyler, J.S., Mahon, J., Krischer, J.P., Beam, C.A., Boulware, D.C., Greenbaum, C.J., Rafkin, L.E., Cowie, C., Cuthbertson, D., Palmer, J.P. Diabetes. Care (2011) [Pubmed]
  4. A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants. Sosenko, J.M., Mahon, J., Rafkin, L., Lachin, J.M., Krause-Steinrauf, H., Krischer, J.P., Cuthbertson, D., Palmer, J.P., Thompson, C., Greenbaum, C.J., Skyler, J.S. Pediatr. Diabetes (2011) [Pubmed]
  5. A Longitudinal Study of GAD65 and ICA512 Autoantibodies During the Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) Participants. Sosenko, J.M., Skyler, J.S., Palmer, J.P., Krischer, J.P., Cuthbertson, D., Yu, L., Schatz, D.A., Orban, T., Eisenbarth, G. Diabetes. Care (2011) [Pubmed]
  6. Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants. Sosenko, J.M., Palmer, J.P., Rafkin, L.E., Krischer, J.P., Cuthbertson, D., Greenbaum, C.J., Eisenbarth, G., Skyler, J.S. Diabetes. Care (2010) [Pubmed]
  7. Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1). Sosenko, J.M., Skyler, J.S., Krischer, J.P., Greenbaum, C.J., Mahon, J., Rafkin, L.E., Cuthbertson, D., Cowie, C., Herold, K., Eisenbarth, G., Palmer, J.P. Diabetes (2010) [Pubmed]
  8. Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1. Sosenko, J.M., Palmer, J.P., Rafkin-Mervis, L., Krischer, J.P., Cuthbertson, D., Mahon, J., Greenbaum, C.J., Cowie, C.C., Skyler, J.S. Diabetes. Care (2009) [Pubmed]
  9. The prevalence of diabetic neuropathy according to ethnicity. Sosenko, J.M. Curr. Diab. Rep. (2009) [Pubmed]
  10. Glucose and C-peptide changes in the perionset period of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Sosenko, J.M., Palmer, J.P., Rafkin-Mervis, L., Krischer, J.P., Cuthbertson, D., Matheson, D., Skyler, J.S. Diabetes. Care (2008) [Pubmed]
  11. A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1. Sosenko, J.M., Krischer, J.P., Palmer, J.P., Mahon, J., Cowie, C., Greenbaum, C.J., Cuthbertson, D., Lachin, J.M., Skyler, J.S. Diabetes. Care (2008) [Pubmed]
  12. Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1. Sosenko, J.M., Palmer, J.P., Greenbaum, C.J., Mahon, J., Cowie, C., Krischer, J.P., Chase, H.P., White, N.H., Buckingham, B., Herold, K.C., Cuthbertson, D., Skyler, J.S. Diabetes. Care (2007) [Pubmed]
  13. Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1. Sosenko, J.M., Palmer, J.P., Greenbaum, C.J., Mahon, J., Cowie, C., Krischer, J.P., Chase, H.P., White, N.H., Buckingham, B., Herold, K.C., Cuthbertson, D., Skyler, J.S. Diabetes. Care (2006) [Pubmed]
  14. Sensory function and albumin excretion according to diagnostic criteria for diabetes. Sosenko, J.M., Kato, M., Goldberg, R.B. Diabetes. Care (2004) [Pubmed]
  15. Albuminuria in recent-onset type 2 diabetes: the Strong Heart Study. Sosenko, J.M., Hu, D., Welty, T., Howard, B.V., Lee, E., Robbins, D.C. Diabetes. Care (2002) [Pubmed]
  16. The epidemiology of neuropathic foot ulcers in individuals with diabetes. Sosenko, J. Curr. Diab. Rep. (2002) [Pubmed]
 
WikiGenes - Universities